Dr. Murakami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana-Farber Cancer Institute, Smith Building, Room 357
Boston, MA 02215Phone+1 617-632-3779Fax+1 617-632-5822
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
Washington University in St. Louis School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2011 - 2026
Publications & Presentations
PubMed
- Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.Marlise R Luskin, Mark Alan Murakami, Julia H Keating, Yael Flamand, Eric S Winer
Blood. 2024-10-07 - 1 citationsBone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance.Mark A Murakami, Laura Connelly-Smith, Thomas Spitzer, Adetola A Kassim, Sam L Penza
Transplantation and Cellular Therapy. 2024-07-01 - Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.Peter S Winter, Michelle L Ramseier, Andrew W Navia, Sachit Saksena, Haley Strouf
Biorxiv. 2024-06-10
Abstracts/Posters
- A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older AdultsMark A. Murakami, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Signaling Input from Divergent Pathways Subverts Malignant B-Cell TransformationMark A. Murakami, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
South Africa: Two International Awards for UCT's Katherine AntelAugust 2nd, 2022
New Public Repository of Patient-Derived Cancer Models Aims to Improve Drug TestingApril 11th, 2016
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
